Glenmark Pharmaceuticals
₹1,541.65
+0.85 (0.06%)
- Advice
- Hold
22 December, 2024 07:04 BSE: 532296
NSE: GLENMARKISIN: INE935A01035
Start SIP in Glenmark Pharmaceuticals
Start SIPGlenmark Pharmaceuticals Performance
Day Range
52 Week Range
Glenmark Pharmaceuticals F&O
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,541.65
+0.85 (0.06%)
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹1,541.10
- 50 Day
- ₹1,575.85
- 100 Day
- ₹1,546.03
- 200 Day
- ₹1,397.32
- 20 Day
- ₹1,529.78
- 50 Day
- ₹1,612.34
- 100 Day
- ₹1,623.38
- 200 Day
- ₹1,373.40
Glenmark Pharmaceuticals Resistance and Support
PIVOT
₹1,544.14
Resistance | |
---|---|
First Resistance | 1,558.22 |
Second Resistance | 1,574.78 |
Third Resistance | 1,588.87 |
RSI | 48.06 |
MFI | 42.47 |
MACD Single Line | -22.98 |
MACD | -16.13 |
Support | |
---|---|
First Support | 1,527.57 |
Second Support | 1,513.48 |
Third Supoort | 1,496.92 |
Glenmark Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 653,660 | 33,003,293 | 50.49 |
Week | 513,746 | 18,166,044 | 35.36 |
1 Month | 688,467 | 26,795,152 | 38.92 |
6 Month | 927,070 | 40,939,401 | 44.16 |
Glenmark Pharmaceuticals Result Highlights
Glenmark Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Glenmark Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend | |
2024-02-14 | Quarterly Results | |
2023-11-10 | Quarterly Results |